| Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120) |
|---|
| 02/06/2008 | CN101120004A 8a,9-dihydro-4ah-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents |
| 02/06/2008 | CN101119970A Azadecalin glucocorticoid receptor modulators |
| 02/06/2008 | CN100366605C Compounds to treat alzheimer's disease |
| 02/05/2008 | US7326791 Carboxylic acid amides, the preparation thereof, and their use as pharmaceutical compositions |
| 02/05/2008 | US7326705 2-amino or carbonylamino-4-carbocyclic imidazoles and thiazoles; antiischemic agents, hypotensive agents, antiarrhythmia agents; can be coadministered with other drugs |
| 02/05/2008 | US7326702 antibiotics, fungicides, viricides; treating microbial infections; fused rings based on 1,4-benzoxazino(2,3,4-ij)quinolin-4-one for example |
| 02/05/2008 | US7326701 Lactam compounds and pharmaceutical use thereof |
| 02/05/2008 | CA2383315C New derivatives of pyrimidin-4-ones, the process for the preparation thereof and the pharmaceutical compounds that contain them |
| 01/31/2008 | WO2008012571A1 Imidazothiazole derivatives as mark inhibitors |
| 01/31/2008 | WO2008012010A1 Fused oxazoles & thiazoles as histamine h3- receptor ligands |
| 01/31/2008 | WO2007123892A3 Raf inhibitors and their uses |
| 01/31/2008 | US20080027221 Azo Dye |
| 01/31/2008 | CA2658627A1 Imidazothiazole derivatives as mark inhibitors |
| 01/30/2008 | EP1882686A2 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/30/2008 | EP1881988A1 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones modulating the function of the vanilloid-1 receptor (vr1) |
| 01/30/2008 | EP1881827A1 Fused thiazole derivatives as kinase inhibitors |
| 01/29/2008 | US7323569 N-cyclopropylmethyl-N-7-[2,6-dimethoxy-4-(methoxymethyl)phenyl]-2-ethylpyrazolo[1,5-a]pyridin-3-yl-N-tetrahydro-2H-4-pyranylmethylamine. |
| 01/29/2008 | US7323458 Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 01/24/2008 | WO2008011045A2 3-ARYL-6-ARYL-7H-[1,2,4]TRIAZOLO[3,4-b][1,3,4]THIADIAZINES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF |
| 01/24/2008 | WO2008009700A1 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones |
| 01/24/2008 | CA2658764A1 Benzothiophene inhibitors of rho kinase |
| 01/24/2008 | CA2658261A1 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones |
| 01/23/2008 | EP1879900A2 Sulfoximine-pyrimidine macrocycles and the salts thereof, a process for making them, and their pharmaceutical use against cancer |
| 01/23/2008 | EP1879886A1 Mitotic kinesin inhibitors and methods of use thereof |
| 01/23/2008 | EP1725232B1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor |
| 01/23/2008 | CN100363368C Thiadiazine derivatives and use thereof as positive ampa receptor modulators |
| 01/22/2008 | US7321040 MAP (mitogen-activated protein) kinase inhibitors; osteoarthritis, rheumatoid arthritis, anticarcinogenic or antiischemic agents; reperfusion injuries, strokes or heart attack; autoimmune, skin, cardiovascular, brain, bone, neurodegenerative, respiratory system and nervous system disorders |
| 01/22/2008 | US7320995 Lung melanoma metastasis, rheumatoid arthritis, 1-isopropylsulfonyl-2-amino-6-(2-(2,6-difluorophenyl)-5-(phenyl)-imidazol-4-yl)-benzimidazole |
| 01/22/2008 | US7320971 Cardenolide glycosides, which have a cytotoxic activity, cancer |
| 01/17/2008 | WO2007120121A3 Oxime and hydroxylamine substituted thiazolo[4,5-c] ring compounds and methods |
| 01/17/2008 | US20080015215 Diamine derivatives |
| 01/17/2008 | US20080015189 Antimicrobial photoinactivation using chalcogen analogs of benzo(A)phenoxazinium dyes |
| 01/16/2008 | EP1877517A2 Luminous compound containing lanthanide ion |
| 01/16/2008 | EP1877404A2 Novel cyclic amines |
| 01/16/2008 | EP1877399A1 Triazole derivatives as vasopressin antagonists |
| 01/16/2008 | EP1877056A2 Oxime and hydroxylamine substituted thiazoloý4,5-c¨ring compounds and methods |
| 01/16/2008 | EP1625126B1 Imidazo and thiazolopyridines as jak3 kinase inhibitors |
| 01/16/2008 | CN101107255A Anthelmintic imidazol-thiazole derivatives |
| 01/15/2008 | CA2210684C Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts |
| 01/10/2008 | WO2008005303A2 Thiazolopyrimidine modulators of trpv1 |
| 01/10/2008 | WO2008003703A1 Indoles as 5-ht6 modulators |
| 01/10/2008 | WO2007104652A3 Non-peptidic renin inhibitors nitroderivatives |
| 01/10/2008 | WO2007053723A8 Process for the preparation of cefdinir |
| 01/10/2008 | US20080009634 Process for synthesizing beta-lactamase inhibitor intermediates |
| 01/10/2008 | US20080009531 5-Anilino-4-Heteroarylpyrazole Derivatives Useful for the Treatment of Diabetes |
| 01/10/2008 | US20080009524 Such as 5'-(1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-2'-methyl-N-(methylsulfonyl)biphenyl-3-carboxamide; cystic fibrosis transmembrane conductance regulator disorders |
| 01/10/2008 | US20080009506 Imidazole Compound |
| 01/10/2008 | US20080009483 3-{[(2,3-dihydro[1,4]dioxino[2,3-c]pyridin-7-ylmethyl)amino]methyl}-N-[3-fluoro-6-(methyloxy)-1,5-naphthyridin-4-yl]-4-hydroxycyclopentanecarboxamide; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli |
| 01/10/2008 | CA2659060A1 Fused heterocyclic inhibitors of d-amino acid oxidase |
| 01/10/2008 | CA2655694A1 1,4-substituted indoles useful for modulation of the 5-ht6 receptor |
| 01/09/2008 | EP1874768A2 Inhibitors of akt activity |
| 01/09/2008 | EP1874741A1 Azole derivatives in the form of lipase and phospholipase inhibitors |
| 01/09/2008 | CN100360539C Preparation of plurichari |
| 01/08/2008 | US7317005 Cyclic oligopeptide; hypotensive agents; congestive heart failure, antiischemic agents, cirrhosis, kidney failure, strokes; thrombosis |
| 01/08/2008 | CA2338600C Novel thiazolopyrimidine compounds |
| 01/08/2008 | CA2225830C Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides |
| 01/03/2008 | WO2008001883A1 α-AMINO ACID DERIVATIVE AND PHARMACEUTICAL COMPRISING THE SAME AS ACTIVE INGREDIENT |
| 01/03/2008 | WO2008001076A1 Fused thiazole derivatives as kinase inhibitors |
| 01/03/2008 | WO2008000646A1 Long wavelength shifted benzotriazole uv-absorbers and their use |
| 01/03/2008 | US20080004262 2,2,7,9-tetramethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-3-ol; 3-hydroxy-2,2,9-trimethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-7-carbonitrile; have the prolongation effect on refractory period |
| 01/03/2008 | US20080003290 Phenethanolamine Derivatives for Treatment of Respiratory Diseases |
| 01/02/2008 | EP1873159A1 Substituted sulphonamido-macrocycles as Tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 01/02/2008 | EP1871776A2 Fused thieno[2,3-b]pyridine and thiazolo[5,4-b]pyridine compounds for inhibiting ksp kinesin activity |
| 01/02/2008 | EP1124828B1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 01/02/2008 | CN101098877A Indoleamine 2,3-dioxygenase (ido) inhibitors |
| 01/02/2008 | CN101098876A Thiazolopyridine derivates, pharmaceutical conditions containing them and methods of treating glucokinase mediated conditions |
| 01/02/2008 | CN100358888C Novel guanidine mimics as factor Xa inhibitors |
| 01/01/2008 | US7314936 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases |
| 01/01/2008 | US7314884 non-insulin dependent diabetes mellitus, and impaired glucose tolerance; dipeptidyl peptidase IV (DPP-IV) inhibitors eg (2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile |
| 12/27/2007 | WO2007150002A2 PRODRUGS OF 5-AMINO-3-(3'-DEOXY-β-D-RIBOFURANOSYL)-THIAZOLO[4,5-d] PYRIMIDIN-2,7-DIONE |
| 12/27/2007 | WO2007148835A1 Agent for overcoming resistance to anti-cancer agent |
| 12/27/2007 | WO2007148185A2 Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors |
| 12/27/2007 | WO2007148113A1 Metabotropic glutamate receptor modulators |
| 12/27/2007 | WO2007147794A1 Furan derivatives and their use as antiviral agents |
| 12/27/2007 | WO2007147575A2 Substituted sulfonamido-macrocycles as tie2 inhibitors and salts thereof, pharmaceutical compositions comprisings same, methods of preparing same and uses same |
| 12/27/2007 | WO2007147574A1 Sulfonamido-macrocycles as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 12/27/2007 | WO2007147346A1 Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof |
| 12/27/2007 | WO2007109120A3 Imidazolothiazole compounds for the treatment of disease |
| 12/27/2007 | US20070299112 Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i |
| 12/27/2007 | US20070299108 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents |
| 12/27/2007 | US20070299102 Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer |
| 12/27/2007 | US20070299101 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment |
| 12/27/2007 | DE102006029573A1 Neue Quinazoline als Kinase-Inhibitoren New quinazolines as kinase inhibitors |
| 12/27/2007 | DE102006029446A1 Neue 3-substituierte-Chinoline als Kinase-Inhibitoren New 3-substituted quinolines as kinase inhibitors |
| 12/27/2007 | DE102006029445A1 Neue 3-Cyano-chinoline als Kinase-Inhibitoren New 3-cyano-quinolines as kinase inhibitors |
| 12/27/2007 | DE102006028649A1 New 5-quinoline derivatives are topoisomerase inhibitors useful to treat bacterial infections |
| 12/27/2007 | CA2655895A1 Agent for overcoming resistance to anti-cancer agent |
| 12/26/2007 | EP1870416A1 Sulphonamido-macrocycles as tie2 inhibitors |
| 12/26/2007 | EP1870403A1 Optically active quaternary ammonium salt having axial asymmetry and process for producing -amino acid and derivative thereof with the same |
| 12/26/2007 | EP1869060A1 Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof |
| 12/26/2007 | EP1869056A1 Novel 5-substituted 7-amino-ý1,3¨thiazoloý4,5-d¨pyrimidine derivatives |
| 12/26/2007 | EP1869055A1 Novel 5,7-disubstituted ý1,3¨thiazoloý4,5-d¨pyrimidin-2(3h)-one derivatives |
| 12/26/2007 | EP1869052A1 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors |
| 12/26/2007 | EP1869010A1 3-sulfonylamino-pyrrolidine-2-one derivatives as factor xa inhibitors |
| 12/26/2007 | EP1869002A1 Substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their preparation and use in medicaments |
| 12/26/2007 | CN101092400A 黄嘌呤氧化酶抑制剂 Xanthine oxidase inhibitors |
| 12/26/2007 | CN100357295C Macrocyclic pyrimidines, their production and use as pharmaceutical agents |
| 12/25/2007 | US7312225 inhibit cyclin-dependent kinases and VEGF-receptor tyrosine kinases |
| 12/25/2007 | US7312212 Bactericides for infrections in man |
| 12/25/2007 | US7312208 Quaternary ammonium compounds |